天宇股份：卡格列净片药品获得批准

Core Viewpoint - Tianyu Co., Ltd. (300702.SZ) announced that its wholly-owned subsidiary, Zhejiang Nuode Pharmaceutical Co., Ltd., has received the drug registration certificate for Canagliflozin Tablets from the National Medical Products Administration (NMPA) [1] Group 1: Product Approval - The product is indicated for use in adult patients with type 2 diabetes to improve blood sugar control when used in combination with Metformin [1] - It can also be used in conjunction with Metformin and sulfonylureas when blood sugar control is inadequate with these medications alone [1] - The product is not recommended for improving blood sugar control in patients with type 1 diabetes [1]